Solvay completes acquisition of Chemlogics

Solvay announced on October 31, 2013, the closing of the acquisition of privately-held Chemlogics, following clearance from the relevant anti-trust authorities. This acquisition, as part of the Group's transformation towards an innovative chemical solutions provider, enables Solvay's Novecare business unit to become a leader with an extensive portfolio of tailored chemical solutions for the fast-growing oil & gas market.
 
The acquisition of Chemlogics will generate significant synergies. Synergies will come from an extended client base and thanks to a comprehensive offering of innovative products and technologies enabling oilfield service players worldwide to competitively and safely extract oil and gas while reducing water consumption.
 
ALSO READ: Deccan Fine Chemicals to buy Bayer CropScience's Gujarat unit

Solvay announced plans to buy Chemlogics for $1,345 million in cash on October 7. Founded in 2002 and headquartered in Paso Robles, California, Chemlogics reported last-twelve-month sales of around $500 million and has 277 employees. All its assets are located in the US and include three manufacturing sites with annual capacity exceeding 300 KT, eight formulation centers and six research and technical facilities.
 
"This acquisition accelerates Solvay's transformation into a Group with higher growth and stronger margins, while increasing its exposure to the growing US energy market. Strengthening Solvay's oil and gas offering fits with our aim to become a model in sustainable chemistry, contributing to the transition towards the use of ever cleaner energy forms for a growing number of consumers," said Jean-Pierre Clamadieu, Chief Executive Officer of Solvay.